Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
25.99
+0.26 (1.01%)
At close: Jan 27, 2026, 4:00 PM EST
25.71
-0.28 (-1.08%)
After-hours: Jan 27, 2026, 7:32 PM EST
Centessa Pharmaceuticals Employees
Centessa Pharmaceuticals had 77 employees as of December 31, 2024. The number of employees increased by 1 or 1.32% compared to the previous year.
Employees
77
Change (1Y)
1
Growth (1Y)
1.32%
Revenue / Employee
$194,805
Profits / Employee
-$3,151,922
Market Cap
3.80B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 77 | 1 | 1.32% |
| Dec 31, 2023 | 76 | -7 | -8.43% |
| Dec 31, 2022 | 83 | -7 | -7.78% |
| Dec 31, 2021 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Legend Biotech | 2,609 |
| ADMA Biologics | 685 |
| Alumis | 223 |
| Liquidia | 170 |
| Arcellx | 163 |
| CG Oncology | 113 |
| Vera Therapeutics | 112 |
| NewAmsterdam Pharma Company | 77 |
CNTA News
- 13 days ago - Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting - GlobeNewsWire
- 15 days ago - Nxera Pharma to Receive US$3.6 Million in Milestone Payment Pursuant to Research Collaboration with Centessa - GlobeNewsWire
- 6 weeks ago - Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications - GlobeNewsWire
- 2 months ago - Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares - GlobeNewsWire
- 2 months ago - Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares - GlobeNewsWire
- 2 months ago - Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program - GlobeNewsWire
- 5 months ago - Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - GlobeNewsWire